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Abstract The telomerase reverse transcriptase (TERT) gene
rs2736100_C allele has recently been shown to be associated
with an increased risk for myeloproliferative neoplasms
(MPNs) among Caucasians. However, it is unknown if this
association is present in other ethnical populations and whether
rs2736100 allele frequencies mirror the incidence of MPNs in a
population. Here we genotyped TERT rs2736100 variants in
126 Swedish and 101 Chinese MPN patients and their age-,
sex-, and ethnically-matched healthy controls. Healthy
Chinese adults had a higher frequency of the A allele and lower
frequencies of the C allele compared to Swedish counterparts
(57.4 vs 47.0 % for A, 42.6 vs 53.0 % for C, P = 0.006). Both
Swedish and Chinese patients harbored significantly higher C
allele frequency than their controls (62.7 vs 53.0 % and 57.4 vs
42.6 % for Swedish and Chinese, respectively, P = 0.004).
Swedes and Chinese bearing the CC genotype had a significant-
ly increased risk of MPN compared to AA carriers (OR = 2.47;
95 % CI: 1.33–4.57, P = 0.003, for Swedes, and OR = 3.45;
95 % CI: 1.52–7.85, P = 0.005, for Chinese). Further analyses
showed that rs2736100_CC was associated with robustly en-
hanced risk in males only (CC vs AA, OR = 5.11; 95 % CI:
2.19–11.92,P < 0.0001). TheCC-carryingMPNpatients exhib-
ited significantly higher TERT expression than patients with
the AC genotype. Collectively, the rs2736100_C is a risk allele
for MPNs in Swedish and Chinese males, and the lower inci-
dence of MPNs in the Chinese population is correlated with a
lower rs2736100_C risk allele frequency.
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Introduction
Philadelphia chromosome negative myeloproliferative neo-
plasms (MPNs), consisting of polycythemia vera (PV), essen-
tial thrombocythemia (ET), and primary myelofibrosis (PMF),
are characterized by hyperproliferation in the bone marrow
leading to an excessive amount of mature cells from one or
more of the myeloid lineages [1]. MPNs generally have a rel-
atively indolent course, representing an early stage of leukemo-
genesis. However, a subset of patients eventually evolves into
myelodysplastic syndrome (MDS) or acute myeloid leukemia
(AML) [1–3]. Several genetic alterations have been identified
in MPNs, with the most common being the JAK2V617F
mutation seen in 95 % of PV and 50 % of ET and PMF.
Other genetic aberrations include calreticulin (CALR) and
thrombopoetin receptor (MPL) mutations that are present in
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70 and 10 % of JAK2V617F-negative ET and PMF, respectively
[1, 4–6]. The identification of these mutations provides pro-
found insights into the pathogenesis of MPNs, but the exact
etiology remains incompletely understood. For instance, the
MPN incidence varies significantly dependent on geographical
areas, from approximately 2/100,000 person-years in China [7]
to 5.8/100,000 person-years in Europe [1, 8], which highlights
differences in genetic susceptibility. However, little is known
about genetic events underlying this difference in incidence
between Caucasians and Chinese.
Telomerase, a RNA-dependent DNA polymerase with
telomerase reverse transcriptase (TERT) as its key catalytic
component, is silent in most normal human cells due to the
transcriptional repression of the TERT gene, whereas TERT
induction coupled with telomerase activation is required for
malignant transformation [9, 10]. The aberrant TERT expres-
sion confers malignant cells infinite proliferative potential.
Similarly, high telomerase activity and TERT expression has
been observed in MPNs [11, 12]. More recently, a number of
studies uncovered an association between the rs2736100 A>C
single nucleotide polymorphism (SNP) in the TERT gene and
the risk of developing MPNs [13–17]. The rs2736100 is lo-
cated at intron 2 of the TERT locus, and its CC genotype was
previously observed to enhance TERT transcription, thereby
increasing cancer risk [18]. However, so far, all the data of the
rs2736100 association with MPN risk have been exclusively
obtained from the analysis of Caucasians. It is currently un-
clear whether this is the case in the Chinese population or if
there is a racial disparity. Moreover, given the significant dif-
ference in MPN incidence betweenWestern and Chinese pop-
ulations, it is important to determine whether the distribution
of rs2736100 genotypes differs between these two ethnic
groups. In the present study, we aimed to address these issues
by genotyping rs2736100 in both Swedish and Chinese MPN
patients and their corresponding healthy controls.
Materials and methods
Study populations
One hundred one Chinese MPN patients and 101 age- and
sex-matched healthy adults were recruited from Shandong
University Hospitals, China. Patients diagnosed with MPN
(N = 126) at the Karolinska University Hospital in Solna,
Stockholm, were also recruited to this study. The SNP
rs2736100 has recently been studied in a Swedish general
population [19], and an age- and sex-matched part of this
population (n = 756) was used as control for the Swedish
MPN patients. The study was approved by the Shandong
University Second Hospital Ethics Committee and
Stockholm Regional Ethics Review Board, and informed con-
sent was obtained from all the participants.
DNA extraction and SNP genotyping
DNA was extracted from blood derived from Swedish and
Chinese MPN patients, and Chinese healthy controls using
QIAmp DNA blood kit (Qiagen, Hilden, Germany). For
Swedish healthy controls, saliva was collected and DNA ex-
tracted using a whole-saliva collection device (Oragene•DNA
sample collection kit; DNAGenotek Inc., Canada) [19]. DNA
concentration was measured on a NanoDrop 2000 spectro-
photometer (Thermo Scientific, Waltham, MA, USA).
Genotyping of rs2736100 was performed using pre-designed
TaqMan SNP genotyping assay kits on a QuantStudio 7 flex
system (Applied Biosystems, Waltham, MA, USA) as previ-
ously described [20]. The assay included negative controls
and was run with the following condition: 95 °C for 10 min
followed by 40 cycles of 92 °C for 15 s and 60 °C for 1 min.
The genotyping success rate was >95 %.
RNA isolation and quantitative reverse
transcription-PCR (qRT-PCR)
Total cellular RNA in granulocytes from MPN patients was
isolated using TRIzol reagent (Life Technologies, Carlsbad,
CA, USA). Two micrograms of RNA was used for reverse
transcription using M-MLV (Life Technologies, Carlsbad,
CA, USA)) according to the manufacturer’s recommendation.
Real-time amplification was performed in triplicate using
SYBR Green PCR Master Mix (Life Technologies, Carlsbad,
CA, USA) with QuantStudio 7 Flex Teal-Time PCR system
(Applied Biosystems, Waltham, MA, USA), and the following
primers were used: TERT, 5′-CGGAAGAGTGTCTG
GAGCAA-3′ (forward) and 5′-GGATGAAGCGGAGT
CTGGA-3′ (reverse); β2-M, 5′-GAATTGCTATGTGTCT
GGGT-3′ (forward) and 5′-CATCTTCAAACCTCCATGAT
G-3′ (reverse). Levels of TERT messenger RNA (mRNA)
were calculated from threshold cycle values and normalized
to β2-M mRNA abundance, and expressed as arbitrary units.
Telomere length analysis with flow-FISH
Telomere length in granulocytes from the Swedish MPN pa-
tients was measured using flow-FISH as previously described
[21]. In short, fluorescent PNA probes (Panagene, Daejeon,
Korea) were hybridized to the telomere sequence and the fluo-
rescent signal was measured using a Gallios flow cytometer
(Beckman Coulter, Brea, CA, USA) and analyzed using the
Kaluza software (Beckman Coulter, Brea, CA, USA).
Fluorescent MESF-FITC beads (Bangs Laboratories,
Fishers, IN, USA) were used and the fluorescent signal was
quantified using the QuickCal v.2.3 data analysis program
(Bangs Laboratories, Fishers, IN, USA).
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Statistical analysis
Age and sex differences between patients and controls were
compared using Mann-Whitney U and Fisher’s exact test,
respectively. Differences in telomere length and TERT
mRNA levels among different genotype groups were deter-
mined using Mann-Whitney U test. Fisher’s exact test was
used to determine odds ratio with 95 % confidence interval
(CI) and P value. All statistical analyses were performed in
GraphPad Prism. P values <0.05 were considered statistically
significant.
Results
Demographic and clinical characteristics of study subjects
A total of 126 MPN patients from Sweden and 101 from
China were genotyped for rs2736100 variants. Clinical
features including age, sex, MPN subtype, and mutation
status (JAK2V617F and CALR mutations) are summarized
in Table 1. Seven hundred fifty-six Swedish and 101
Chinese healthy age- and sex-matched adults were used
as controls (Table 1). ET were more common and PV
more uncommon among the Chinese patients than the
Swedish patients. The Chinese patients were also younger
than the Swedish patients.
Different rs2736100 allele distributions in healthy Swedish
and Chinese populations
We first compared the distribution of rs2736100 genotypes in
the healthy Swedish and Chinese control populations. As
shown in Table 2, the Chinese population had lower C and
higher A allele frequencies than the Swedish population (42.6
vs 53.0 % for C and 57.4 vs 47.0 % for A, respectively, P =
0.006). To verify whether this finding was representative, we
further collected published genotyping data from another co-
hort of 289 healthy adults from the Shandong area (north) [22]
and one from south of China (Shanghai and Guangzhou areas)
[18]. Both of them showed a rs2736100 genotype distribution
very similar to that of the present study (Table 3). The
rs2736100 allele/genotype distribution in healthy populations
from Sweden and other European countries (south and east)
[15, 16] was also compared to the healthy populations in
China. All of the previously published studies displayed large-
ly similar rs2736100 variant frequency, with significantly
higher C while lower A alleles in European countries (48.0
vs 57.4 % and 52.0 vs 42.6 % for A and C, respectively,
P < 0.001). There was no difference in the AC genotype
between Chinese and Caucasians (Tables 2 and 3).
Rs2736100_C allele association with risk of MPN
Given different distributions of the rs2736100 allele frequency
between control populations from two different countries, we
chose to analyze the Swedish and Chinese MPN patients sepa-
rately. The rs2736100_C allele frequency was significantly
higher in both Swedish and Chinese MPN patients than in their
corresponding controls (62.7 vs 53.0 % and 57.4 vs 42.6 % for
Swedish andChinese patients, respectively,P = 0.004) (Table 4).
Compared to the AA variant carriers, Swedish and Chinese pa-
tients bearing the CC genotype exhibited significantly increased
Table 1 Characteristics of healthy controls and patients with MPN
Sweden China
Controls MPN Controls MPN
Number 756 126 101 101
Age (years)
Mean ± SD 64 ± 5 64 ± 14 58 ± 15 58 ± 15
Median (range) 64 (54–74) 65 (25–106) 60 (17–82) 60 (17–82)
Sex [%females] 53 53 50 50
MPN subtype, n (%)
PV 41 (32.5) 16 (15.8)
ET 40 (31.7) 38 (37.6)
PMF 28 (22.3) 15 (14.9)
MPN-NOS 17 (13.5) 32 (31.7)
JAK2-status, n (%)
JAK2 V617F− 60 (47.6) 38 (37.6)
JAK2 V617F+ 66 (52.4) 56 (55.4)
Unknown 0 7 (7.0)
CALR mutation 45 Unknown
MPN myeloproliferative neoplasm, PV polycythemia vera, ET essential
thrombocythemia, PMF primary myelofibrosis
Table 2 Comparison of genotype distribution of TERT rs2736100 in
healthy control populations in Sweden and China
Sweden China
rs2736100 N (%) N (%) P value
Genotype 756 (100) 101 (100)
AC+CC 589 (77.9) 68 (67.3) 0.024
AA 167 (22.1) 33 (32.7)
AA+CC 379 (50.1) 51(50.5) 0.916
AC 377 (49.9) 50 (49.5)
AA+AC 544 (72.0) 83 (82.2) 0.031
CC 212 (28.0) 18 (17.8)
Allele A 711 (47.0) 116 (57.4) 0.006
C 801 (53.0) 86 (42.6)
OR and P-value generated using Fishers' exact test
Significant p-values are shown in italic
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risk of MPN (OR = 2.47; 95 % CI: 1.33–4.57, P = 0.003, for
Swedish, and OR = 3.45; 95 % CI: 1.52–7.85, P = 0.005, for
Chinese patients) (Table 4). The AC genotype was also associ-
ated with an increased risk of MPN, but the P value for Chinese
was at borderline significance, likely due to relatively few pa-
tients (AC vs AA: OR = 2.02; 95 % CI: 1.00–4.08, P = 0.057,
for Chinese, and OR = 1.89; 95 % CI: 1.05–3.41, P = 0.034, for
Swedish). Higher frequency of C alleles or CC genotypes was
observed in all MPN subtypes, and there was no significant
difference among patients with PV, ET, and PMF, respectively.
rs2736100_C allele association with risk of MPN in males
As shown in Table 5, there was no difference in the rs2736100
allele distribution between control males and females.
However, MPN patients displayed a sex-dependent variant dif-
ference: male patients carried significantly more C alleles than
control males did (66.8 vs 52.5 %, P < 0.001), and the AC and
CC genotypes were associated with increased risk of MPNs in
males compared to the AA variant (OR = 3.48; 95 % CI: 1.53–
7.91, P = 0.002, for AC; OR = 5.11; 95 % CI: 2.19–11.92,
Table 3 Published rs2736100 genotype distributions of healthy populations in China and Europe
Author Number AA (%) AC (%) CC (%) A (%) C (%) Area Reference
China
Dahlström et al. 101 33 (32.7) 50 (49.5) 18 (17.8) 116 (57.4) 86 (42.6) Northa This study
Yuan et al. 289 86 (29.8) 144 (49.8) 59 (20.4) 316 (54.7) 262 (45.3) Northa [18]
Wei et al. 2520 814 (32.3) 1269 (50.4) 437 (17.3) 2897 (57.5) 2143 (42.5) Southb [16]
Total 2910 933 (32.1)* 1463 (50.3)* 514 (17.6)* 3329 (57.2)* 2491 (42.8)*
Europe
Dahlström et al. 756 167 (22.1) 377 (49.9) 212 (28.0) 711 (47.0) 801 (53.0) Sweden This study
Jäger et al. 202 47 (23.3) 88 (43.6) 67 (33.2) 182 (45.0) 222 (55.0) Italy [14]
Krahling et al. 400 111 (27.8) 188 (47.0) 101 (25.2) 410 (51.3) 390 (48.7) Hungary [13]
Total 1358 325 (23.9)** 653 (48.0)** 380 (28.1)** 1303 (48.0)** 1413 (52.0)**
AA vs AC+CC AC vs AA +CC CC vs AA+AC C vs A
P value (* vs **) <0.001 0.106 <0.001 <0.001
OR and P value were generated using chi-squared test
a From Shandong area
b From Shanghai and Guangzhou areas
Table 4 Comparison of TERT rs2736100 genotypes in MPN patients and healthy controls
rs2736100 genotype Sweden China
Control MPN Control MPN
n (%) n (%) OR (95 % CI) P n (%) n (%) OR (95 % CI) P
All 756 (100) 126 (100) 101 (100) 101 (100)
Alleles
A 711 (47.0) 94 (37.3) 1.0 (ref) 116 (57.4) 86 (42.6) 1.0 (ref)
C 801 (53.0) 158 (62.7) 1.49 (1.13-1.96) 0.004 86 (42.6) 116 (57.4) 1.82 (1.23-2.70) 0.004
Genotypes
AA 167 (22.1) 15 (11.9) 1.0 (ref) 33 (32.7) 17 (16.8) 1.0 (ref)
AC 377 (49.9) 64 (50.8) 1.89 (1.05-3.41) 0.034 50 (49.5) 52 (51.5) 2.02 (1.00-4.08) 0.057
CC 212 (28.0) 47 (37.3) 2.47 (1.33–4.57) 0.003 18 (17.8) 32 (31.7) 3.45 (1.52–7.85) 0.005
AA+AC 544 (72.0) 79 (62.7) 1.0 (ref) 83 (82.2) 69 (68.3) 1.0 (ref)
CC 212 (28.0) 47 (37.3) 1.53 (1.03–2.27) 0.044 18 (17.8) 32 (31.7) 2.14 (1.11–4.14) 0.033
AC+CC 589 (77.9) 111 (88.1) 1.0 (ref) 68 (67.3) 84 (83.2) 1.0 (ref)
AA 167 (22.1) 15 (11.9) 0.48 (0.27–0.84) 0.009 33 (32.7) 17 (16.8) 0.42 (0.21–0.81) 0.014
OR and P value were generated using Fishers’ exact test
MPN myeloproliferative neoplasms, OR odds ratio, CI confidence interval
Significant p-values are shown in italic
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P < 0.0001, for CC) (Table 5). In contrast, no differences in
rs2736100 variants were observed between female controls and
female patients (Table 5). Within the patient population, men
were less likely to harbor the AA variant (OR = 0.25; 95 % CI:
0.10–0.61, P < 0.001) whereas no difference was seen in the
healthy population (Table 5).
Rs2736100 variant association with JAK2V617F
and CALR mutations in MPNs
The relationship between major molecular subtypes in
MPN (JAK2V617F and CALR mutations) and rs2736100
variants was analyzed. The association between CALR
and rs2736100 was only studied in the Swedish MPN
patients. There was no association between any specific
TERT rs2736100 variant and the presence of JAK2V617F.
Patients harboring CALR mutations (insertion or deletion)
(n = 45) tended to have a lower frequency of the CC var-
iant compared to those carrying wt CALR, but the differ-
ence did not reach a significant level (OR = 0.44; 95 %
CI: 0.20–1.01, P = 0.07).
The relationship of rs2736100 variants with TERT
expression and telomere length in MPNs
TERT mRNA expression and leukocyte telomere length was
previously assessed in the Swedish cohort of MPN patients
[21], and we thus further determined a potential impact of dif-
ferent rs2736100 genotypes on TERT expression and telomere
homeostasis. Patients bearing the CC genotype expressed the
highest levels of TERTmRNA compared to those with AA and
AC variants. There was a significant difference between
AC- and CC-carrying patients (P = 0.024). The lowest
TERT expression was observed in patients with AA ge-
notype, but the difference was not significant, likely due
to too few patients (N = 5). In MPN patients there was
no correlation between rs2736100 allele variant and
telomere length (Fig. 1).
Discussion
The TERT rs2736100_C allele has recently been identified to
be associated with increased risk of MPNs based on analyses
of Caucasian patients [13–16]. This finding provides signifi-
cant insights into genetic susceptibility to MPN. However, a
number of issues remain to be defined: first, it is well known
that racial disparities exists in both germline and somatic ge-
netic alterations in the pathogenesis of cancer [22]. Thus, it is
important to evaluate whether the correlation between
rs2736100 allele variant and risk of MPN is also observed in
other ethnic populations. Second, it is currently unclear
whether the influence of TERT rs2736100_C allele on MPN
susceptibility is identical in both males and females. Third,
there is a threefold difference in MPN incidence between
European countries and China, but the underlying mechanism
is unclear. Is there a link between rs2736100 frequency distri-
bution andMPN incidence? Finally, abnormal telomere length
and structure is widespread in MPNs [11, 21], and it is un-
known whether different rs2736100 variants influence TERT
expression and telomere length differentially in MPNs. To
answer these questions we recruited healthy adults and MPN
patients from both Sweden and China for rs2736100 genotyp-
ing. The results presented here demonstrate that (i) the
Table 5 Genotypes of TERT rs2736100 in men and women
rs2736100 genotype Men Women
Control MPN Control MPN
n (%) n (%) OR (95 % CI) P n (%) n (%) OR (95 % CI) P
All 405 (100) 110 (100) 452 (100) 117 (100)
A 385 (47.5) 73 (33.2) 1.0 (ref) 442 (48.9) 107 (45.7) 1.0 (ref)
425 (52.5) 147 (66.8) 1.82 (1.33–2.49) <0.001 462 (51.1) 127 (54.3) 1.14 (0.85–1.52) 0.420
AA 87 (21.5) 7 (6.4) 1.0 (ref) 113 (25.0) 25 (21.4) 1.0 (ref)
AC 211 (52.1) 59 (53.6) 3.48 (1.53–7.91) 0.002 216 (47.8) 57 (48.7) 1.19 (0.71–2.01) 0.601
CC 107 (26.4) 44 (40.0) 5.11 (2.19–11.92) <0.0001 123 (27.2) 35 (29.9) 1.29 (0.72–2.28) 0.469
Control MPN
Men Women Men Women
AC+CC 318 (78.5) 339 (74.3) 1.0 (ref) 103 (93.6) 92 (78.6) 1.0 (ref)
AA 87 (21.5) 113 (25.7) 0.82 (0.60–1.13) 0.227 7 (6.4) 25 (21.4) 0.25 (0.10–0.61) 0.001
OR and P value were generated using Fisher’s exact test
OR odds ratio, CI confidence interval
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rs2736100_C allele is significantly associated with susceptibil-
ity to MPNs in both Swedish and Chinese individuals, but the
association was restricted to male patients; (ii) the Chinese
healthy population bears significantly lower rs2736100_C
but higher A alleles than their Swedish counterpart, which is
highly consistent with the lower incidence of MPNs in China;
(iii) the rs2736100_CC-carrying Swedish patients display
highest TERT expression in their myeloid cells.
The accumulated evidence suggests a close connection be-
tween germline genetic variation and susceptibility to human
diseases. Given TERTs critical role in carcinogenesis, SNPs at
the TERT locus have been extensively analyzed for their as-
sociation with cancer risk, among which rs2736100 variants
are most studied [18, 20, 23–25]. Indeed, the rs2736100_C
allele is reported to increase the risk of multiple types of can-
cer [18, 20, 23–25]. It is believed that the CC genotype pro-
motes TERT transcription, thereby upregulating telomerase
activity and maintaining telomere length required for unlimit-
ed proliferation of cancer cells [18]. Similarly, high telomerase
activity in the bone marrow of patients with MPN has been
reported [12]. Meanwhile, telomere shortening is well
established in MPN myeloid cells [11, 21, 26], likely due to
the hyperproliferation of these cells inMPNs. In this study, we
did observe the highest TERT expression in granulocytes de-
rived from MPN patients bearing the CC genotype. These
results indicate that the C allele may be able to upregulate
TERT expression and in turn compensate for overerosion of
telomere length in MPNs. In addition, TERT possesses many
other important activities independent of its telomere-
lengthening function [27–30], which has been implicated in
cancer development and progression. It is conceivable that
these TERT effects may similarly contribute to MPN
pathogenesis.
Racial or ethnic disparities in disease incidence and patho-
genesis have beenwell documented, and different genetic back-
grounds are believed to play important parts. Likewise, there is
a significant difference in the MPN incidence between Han
Chinese (2/100,000) and European Caucasians (5.8/100,000)
[8]. However, the underlying mechanism remains poorly un-
derstood. In the present study, we found that the rs2736100_C
allele contributed to susceptibility to MPNs in both Swedish
and Chinese populations. Moreover, the frequency of the A and
C allele was significantly higher and lower, respectively, in
Chinese controls than in Swedish and European Caucasian
controls. These findings collectively reveal a positive correla-
tion between MPN incidence and the rs2736100_C allele fre-
quency. As rs2736100_C alleles are associated with an in-
creased risk of many other malignancies [18, 20, 23–25], it is
of interest to determine whether the same pattern can be iden-
tified in other malignancies where the incidence is lower in
China than in Europe. In addition to TERT rs2736100, some
other genetic variants have also been identified to be associated
with MPN risk [17] and further comparison of their variant
frequency between Chinese and Caucasians may contribute to
a better understanding of germline variant effects on MPN
incidence.
Intriguingly, our results showed a significant association of
rs2736100_C with susceptibility to MPNs only in males. This
observation is likely unbiased, because there is no difference in
the rs2736100 genotype distribution between males and fe-
males in the general population in Sweden or China.
Information on association between gender and allele variant
of TERT rs2736100 in MPN patients is lacking in the majority
of published studies [14–16], but one study reported a similar
variant distribution in men and women [13]. Among MPN
patients, women have been reported to have superior survival
compared to men [31, 32]. One study reports that the shorter
overall survival seen in male MPN patients is mainly due to
increased frequency of secondary AML transformation [32],
whereas another states that there are no gender differences in
the risk of developing a secondary malignancy [33]. The CC
genotype of TERT rs2736100 has also been associated with
poorer response to anticancer agents and with cancer-
promoting mutations, such as mutations in P53 [34]. Krahling
Fig. 1 TERT mRNA expression and telomere length in MPN patients
with different TERT rs2736100 variants. Total cellular RNA and genomic
DNA were extracted from granulocytes derived from Swedish MPN
patients harboring different TERT rs2736100 genetic variants. TERT
mRNA and telomere length were measured by using qRT-PCR and
flow-FISH, respectively. a TERT mRNA expression and (b) telomere
length. *P < 0.05
1830 Ann Hematol (2016) 95:1825–1832
et al. recently reported that MPN patients with the CC genotype
had a higher probability to die from secondary solid tumors
[15]. Taken together, these data indicate that the adverse out-
come seen in male MPN patients may be associated with the
rs2736100_CC genotype. Further studies are needed to verify
and define the mechanistic role of rs2736100 variants in MPN
progression and response to treatment.
We observed that the rs2736100_C allele was evenly dis-
tributed in all three subtypes of MPNs (PV, ET, and MF) with
different genetic mutations (JAK2V617F or CALR mutations).
Similar findings were also documented in publications by
Trifa et al. and others [13, 17]. These data collectively suggest
that the C allele serves as a general risk factor for MPNs with
no preferential susceptibility to a specific molecular subtype.
In summary, we demonstrate that the rs2736100_C allele is
associated with increased risk to develop MPNs in both
Swedish and Chinese populations. The direct comparison of
the rs2736100 genotype between Swedish and Chinese
healthy individuals shows a higher A but lower C allele fre-
quency in Chinese individuals, which is correlated with a low-
er MPN prevalence in China. Further studies are required to
dissect a causal relationship between the rs2736100_C allele
and MPN development. These studies are needed to define
how this allele contributes to MPN pathogenesis and to eval-
uate its possible role in AML transformation and disease
progression.
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